EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Epigenetic Age Acceleration and Cardiometabolic Biomarkers in Response to Weight‐Loss Dietary Interventions Among Obese Individuals: The MACRO Trial

Minghao Kou iD, Xiang Li iD, Yoriko Heianza, Kirsten Dorans, Lydia Bazzano, Lu Qi

Aging Cell · 2025

DOI: 10.1111/acel.70224 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Aging Cell, 2025. Verfasst von Minghao Kou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Obesity, Biomarkers, Epigenesis, Genetic, Weight Loss. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic clocks have emerged as promising biomarkers of aging, but their responsiveness to lifestyle interventions and relevance for short‐term changes in cardiometabolic health remain uncertain. In this study, we examined the associations between three epigenetic aging measures (DunedinPACE, PCPhenoAge acceleration, and PCGrimAge acceleration) and a broad panel of cardiometabolic biomarkers in 144 obese participants from the MACRO trial, a 12‐month weight‐loss dietary intervention comparing low‐carbohydrate and low‐fat diets. At pre‐intervention baseline, DunedinPACE was significantly associated with several cardiometabolic biomarkers (FDR [false discovery rate] < 0.05), including insulin, homeostatic model assessment for insulin resistance (HOMA‐IR), total cholesterol, high‐density lipoprotein cholesterol, C‐reactive protein, adiponectin, and ghrelin. These associations were substantially attenuated following the intervention, with only CRP and adiponectin remaining significant. Changes in epigenetic aging measures were not significantly associated with changes in biomarkers, nor did they mediate the effects of weight loss. Our findings highlight DunedinPACE as a sensitive biomarker of cardiometabolic health in adults with obesity but raise questions about the utility of epigenetic clocks as causal targets in short‐term lifestyle interventions. While caloric restriction may attenuate some phenotypic manifestations of biological aging, short‐term changes in epigenetic aging measures may not fully reflect underlying cardiometabolic changes. These results underscore the need for caution in interpreting epigenetic aging as a modifiable intervention target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityBiomarkersEpigenesis, GeneticWeight LossAgingHumansMaleFemaleMiddle AgedAdult

Stichwörter der Autor:innen

DNA methylationagingcardiometabolic healthdietary intervention

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Epidemiology, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.
  • Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois Chicago, Chicago, Illinois, USA.
  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Minghao Kou, Xiang Li

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Kou, M., Li, X., Heianza, Y., Dorans, K., Bazzano, L., & Qi, L. (2025). Epigenetic Age Acceleration and Cardiometabolic Biomarkers in Response to Weight‐Loss Dietary Interventions Among Obese Individuals: The MACRO Trial. Aging Cell. https://doi.org/10.1111/acel.70224

Vancouver

Kou M, Li X, Heianza Y, Dorans K, Bazzano L, Qi L. Epigenetic Age Acceleration and Cardiometabolic Biomarkers in Response to Weight‐Loss Dietary Interventions Among Obese Individuals: The MACRO Trial. Aging Cell. 2025. doi:10.1111/acel.70224

BibTeX
@article{Kou2025,
  author = {Kou, Minghao and Li, Xiang and Heianza, Yoriko and Dorans, Kirsten and Bazzano, Lydia and Qi, Lu},
  title = {Epigenetic Age Acceleration and Cardiometabolic Biomarkers in Response to Weight‐Loss Dietary Interventions Among Obese Individuals: The MACRO Trial},
  journal = {Aging Cell},
  year = {2025},
  doi = {10.1111/acel.70224}
}
Kostenlos starten →